In immune-mediated colitis model, it was further shown that TNFR2 pathway, but not TNFR1 signaling, increases MLCK expression resulting in tight junction dysregulation, barrier loss, and more severe disease (93). This evidence concerns the gene TNFRSF1A and colitis.